CN Patent

CN120417892A — 透皮吸收制剂及其制备方法

Assigned to WHANIN PHARMACEUTICAL CO Ltd · Expires 2025-08-01 · 1y expired

What this patent protects

在根据本发明的透皮吸收制剂及其制备方法中，所述透皮吸收制剂包含含药粘合层，所述含药粘合层包含作为活性成分的罗替高汀或其药学上可接受的盐、作为结晶防止剂的羟丙基纤维素(HPC)、以及有机硅基聚合物粘合剂。

USPTO Abstract

在根据本发明的透皮吸收制剂及其制备方法中，所述透皮吸收制剂包含含药粘合层，所述含药粘合层包含作为活性成分的罗替高汀或其药学上可接受的盐、作为结晶防止剂的羟丙基纤维素(HPC)、以及有机硅基聚合物粘合剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN120417892A
Jurisdiction
CN
Classification
—
Expires
2025-08-01
Drug substance claim
No
Drug product claim
No
Assignee
WHANIN PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.